美媒：马斯克“开创”了脑机接口，但中国正在快速发展

Core Insights - The Chinese brain-computer interface (BCI) industry is rapidly transitioning from research to commercialization, driven by increased policy support, expanded clinical trials, and growing investor interest [1][2] Group 1: Market Potential and Growth - The market for brain-computer interfaces in China is expected to reach several billion dollars, with applications primarily in the healthcare sector over the next three to five years [2][3] - The Chinese market for brain-computer interfaces is projected to grow from 3.2 billion RMB in 2024 to over 3.8 billion RMB (approximately 530 million USD) in 2025, with forecasts suggesting it will exceed 120 billion RMB by 2040 [5] Group 2: Factors Driving Development - Four key factors are propelling the rapid advancement of the BCI industry in China: strong policy support, abundant clinical resources, mature manufacturing capabilities, and strategic market investments [2][3][4] - The establishment of a 11.6 billion RMB (approximately 1.65 million USD) special fund for brain science aims to support the entire process from R&D to commercialization [2] Group 3: Clinical Advancements - Chinese researchers have completed the country's first fully implanted wireless brain-computer interface clinical trial, allowing paralyzed patients to control devices without external hardware [3] - Over 50 clinical trials of flexible implanted brain-computer interfaces are expected to be completed by mid-2025, with advancements in areas such as movement and language decoding, spinal cord reconstruction, and stroke rehabilitation [3] Group 4: Investment and Financing - Recent significant financing activities in the Chinese BCI sector include a 350 million RMB (approximately 48 million USD) Series B funding round for Shanghai-based startup Ladder Medical [4] - Strong Brain Technology, which focuses on non-invasive brain-computer interfaces and bionic limbs, has completed a 2 billion RMB (approximately 287 million USD) funding round and is preparing for an IPO in Hong Kong [4] Group 5: Competitive Landscape - Chinese BCI startups are accelerating their development to challenge industry leaders like Neuralink, Synchron, and Paradromics, with active companies including Brain Tiger Technology, Bo Rui Kang, Ladder Medical, and others [5]